These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 7564365)

  • 1. Relative contribution of alpha 1-adrenoceptor blocking activity to the hypotensive effect of the novel calcium antagonist monatepil.
    Sugimoto T; Hosoki K; Karasawa T
    J Cardiovasc Pharmacol; 1995 Jul; 26(1):55-60. PubMed ID: 7564365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preventive effect of a new calcium antagonist, monatepil, on drug-induced ischaemic electrocardiographic changes in rats.
    Yamamoto T; Nakatsuji K; Hosoki K; Karasawa T
    Clin Exp Pharmacol Physiol; 1993 Nov; 20(11):673-8. PubMed ID: 8306512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-atherosclerotic and plasma lipid lowering effects of the novel calcium blocker with alpha 1-adrenoceptor antagonistic activity, monatepil, in high cholesterol diet-fed Japanese Macaca fuscata monkeys.
    Miyazaki M; Hosoki K; Okunishi H; Ishii K; Ikeno A; Okazaki Y
    Arzneimittelforschung; 1994 Mar; 44(3):288-97. PubMed ID: 8192692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antihypertensive, antiatherosclerotic, and plasma lipid-lowering effects of monatepil, a novel calcium antagonist with alpha 1-adrenoceptor-blocking activity in experimental animals.
    Miyazaki M
    Am J Hypertens; 1994 Oct; 7(10 Pt 2):131S-40S. PubMed ID: 7826563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of lipid hydroperoxidation of low density lipoprotein by the Ca(2+)-channel and alpha 1-adrenoceptor antagonist monatepil maleate.
    Hayashi K; Kuga Y; Nomura S; Okura Y; Tanaka K; Yasunobu Y; Nomura K; Shingu T; Kuwashima J; Kajiyama G
    Arzneimittelforschung; 1996 Apr; 46(4):378-81. PubMed ID: 8740082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on calcium antagonistic and alpha 1-adrenergic receptor blocking activities of monatepil maleate, its metabolites and their enantiomers.
    Honda Y; Masuda Y; Yoshida T; Sato F; Kurokawa M; Hosoki K
    Arzneimittelforschung; 1995 Oct; 45(10):1057-60. PubMed ID: 8595057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological activity of DC-015, a novel potent and selective alpha 1-adrenoceptor antagonist.
    Yen MH; Sheu JR; Peng IH; Lee YM; Chern JW
    J Pharm Pharmacol; 1996 Jan; 48(1):90-5. PubMed ID: 8722503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological studies on a new antihypertensive agent, S-2150, a benzothiazepine derivative: 2. Hypotensive effects in normotensive and hypertensive rats.
    Kawakami M; Matsumura S; Shimamura T; Iwasaki T; Furukawa H; Matsunaga K; Yonetani Y; Iwaki K
    J Cardiovasc Pharmacol; 1996 Nov; 28(5):695-702. PubMed ID: 8945684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-arrhythmic effects of a new calcium antagonist, monatepil, AJ-2615, in experimental arrhythmic models [corrected].
    Yamamoto T; Hosoki K; Karasawa T
    Clin Exp Pharmacol Physiol; 1993; 20(7-8):497-500. PubMed ID: 8403530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro and in vivo electrocardiographic evaluation of the novel calcium antagonist monatepil on cardiac conduction system.
    Nose I; Kataoka T; Honda Y; Yamada T; Ikeno A; Fukuya F; Minato H; Takeyama K; Hosoki K; Karasawa T
    Arzneimittelforschung; 1993 Jul; 43(7):722-8. PubMed ID: 8369002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of the new calcium antagonist monatepil on cardiac function and myocardial oxygen supply and demand in animals.
    Kataoka T; Nose I; Honda Y; Yamada T; Hatano N; Masuda Y; Hosoki K; Karasawa T
    Arzneimittelforschung; 1993 Dec; 43(12):1303-9. PubMed ID: 8141817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Up-regulation of hepatic LDL receptor gene expression by monatepil, a novel calcium antagonist, in high cholesterol diet-fed Japanese monkeys.
    Notake M; Kondo Y; Nomura H; Nakano K; Hosoki K; Miyazaki M
    Am J Hypertens; 1994 Nov; 7(11):1026-30. PubMed ID: 7848617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of monatepil maleate, a new Ca2+ channel antagonist with alpha1-adrenoceptor antagonistic activity, on cholesterol absorption and catabolism in high cholesterol diet-fed rabbits.
    Ikeno A; Sumiya T; Minato H; Fujitani B; Masuda Y; Hosoki K; Kurono M; Yasuba M
    Jpn J Pharmacol; 1998 Nov; 78(3):303-12. PubMed ID: 9869264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preventive effect of monatepil on thromboxane A2 agonist-induced myocardial ischemia in rats.
    Yamamoto T; Hosoki K; Kikuta C; Karasawa T
    Arzneimittelforschung; 1994 Jun; 44(6):712-4. PubMed ID: 8053969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of adrenoceptor blockade and hypotension elicited by urapidil and prazosin in conscious rat.
    Goering J; Zimmerman BG
    J Pharmacol Exp Ther; 1986 May; 237(2):553-7. PubMed ID: 2871176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antihypertensive effects of AJ-2615, a new calcium antagonist with alpha 1-adrenergic blocking activity in experimental hypertensive animals.
    Ikeno A; Nose I; Fukuya F; Minato H; Takeyama K; Hosoki K; Karasawa T
    J Cardiovasc Pharmacol; 1993 May; 21(5):815-21. PubMed ID: 7685454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-hypertension effect of vanylidilol: a phenylaldehyde alpha/beta-adrenoceptor blocker with endothelium-dependent and K+ channels opening-associated vasorelaxant activities.
    Chiu CC; Wu JR; Lee CH; Liou SF; Dai ZK; Chen IJ; Yeh JL
    Pharmacology; 2004 Mar; 70(3):140-51. PubMed ID: 14752234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of monatepil, a novel calcium antagonist with alpha 1-adrenergic blocking activity, on the low-density lipoprotein receptor in human skin fibroblasts.
    Matsunaga A; Inoue T; Koga T; Mori K; Kugi M; Sasaki J; Arakawa K
    Cardiovasc Drugs Ther; 1997 Dec; 11(6):747-50. PubMed ID: 9512869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between the hypotensive and alpha-adrenoceptor blocking actions of prazosin.
    Oates HF
    Arch Int Pharmacodyn Ther; 1979 Feb; 237(2):282-7. PubMed ID: 39527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative effects of monatepil, a novel calcium antagonist with alpha 1-adrenergic-blocking activity, and nitrendipine on lipoprotein and carbohydrate metabolism in patients with hypertension.
    Sasaki J; Ogihara T; Yokoyama M; Kajiyama G; Mashiba H; Sunaga T; Nonaka K; Shichiri M; Tanaka N; Arakawa K
    Am J Hypertens; 1994 Oct; 7(10 Pt 2):161S-166S. PubMed ID: 7826567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.